Budgeting 101 Why Verve Therapeutics Zoomed 40% Higher This WeekBy Dan Brown18/04/20250 Good news from the laboratory and a clutch of bullish analyst notes were the drivers behind Verve Therapeautics’ (VERV 2.00%) big…
Budgeting 101 Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics SlideBy Dan Brown17/04/20250 Eli Lilly has a plan to dominate the GLP-1 weight loss drug market — and it’s succeeding. It’s Thursday morning,…
